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Epithelial–mesenchymal interactions are critical for the formation of gastrointestinal buds such as the cecum from the midgut, but
the mechanisms regulating this process remain unclear. To investigate this problem, we have studied the temporal and spatial
expression of key genes known to orchestrate branching morphogenesis. At E10.5, Fibroblast growth factor 10 (Fgf10) is specifically
expressed in the mesenchyme above the future cecal epithelial bud, whereas Fgfr2b is found throughout the gut epithelium. From
E11.5 onwards, Fgf10 expression is found throughout the cecum mesenchyme. Other relevant signaling molecules such as Sonic
hedgehog, Wnt2b, and Tbx4 transcripts are found throughout the gut epithelium, including the cecum. Epithelial expression is also seen
for Sprouty2, but only from E14.5 onwards. By contrast, Bone morphogenetic 4 (Bmp4) and Pitx2 are specifically expressed in the
mesenchyme of the cecal bud at E11.5. Abrogation of either Fgf10 or Fgfr2b leads to similar phenotypes characterized by an arrest of
epithelial invasion into the cecal mesenchymal tissue. However, a bud of undifferentiated cecal mesenchymal tissue is maintained
throughout development. Our results further indicate that mesenchymal FGF10 acts mostly through the epithelial FGFR2b receptor;
thereby triggering invasion of the midgut epithelium into the adjacent mesenchyme via an increased rate of epithelial proliferation at
the tip of the cecum. Thus, FGF10 signaling via FGFR2b appears to be critical in the extension of the epithelium into the
mesenchyme during cecal development.
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Introduction intestinal tract (GIT). In addition the cecum is easilyThe cecum is an intestinal appendage in the midgut at
the junction of the small and large intestine. In mouse and
other mammals, this organ functions to facilitate microbial
fermentation of the ingested material. Because of its simple
anatomy and reproducible embryonic location at the border
of the small and large intestine, the cecum provides an
ideal model for evaluating the development of the gastro-0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.09.021
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E-mail address: sbellusci@chla.usc.edu (S. Bellusci).accessible, located outside the ventral abdominal wall of
the embryo (physiologic herniation) between embryonic
day 12.5 (E12.5) and E15.5. The embryonic cecum is a
tube composed of two layers. The internal layer, the
endoderm, develops into a simple columnar epithelium
with an absorptive and secretory function. The external
layer, the mesoderm, gives rise to several layers of
differentiated mesenchyme responsible for the important
peristaltic function of the GIT. These include the lamina
propria, muscularis mucosa, submucosa, muscularis
externa, and serosa (Calhoun, 1954; Romanoff, 1960).
Importantly, the cecum develops as a bud propagating
off the main gut tube early in the differentiation of the
GIT (E11.5). Cecal morphogenesis requires bud initiation,
growth (elongation), differentiation, and arrest. It therefore
Fig. 1. Normal development of the cecum. (A) Dissection of the gastrointestinal tract (GIT) with lungs and trachea attached at E12.5 demonstrates the cecum
located at the junction of the small and large intestines. (B) The first evidence of cecal organogenesis is at E11.5, a small bud of mesenchymal tissue (shown
with black arrow) forms in the second intestinal loop at the junction of the small and large intestine. (C) The epithelial layer develops within the early cecal
mesenchymal bud (shown with black arrow) to form a tube-like structure lined with epithelium. The cecum at this stage is in the elongation phase. (D) At
E18.5, the cecum (shown with white arrow) has developed considerable length. Near the completion of the fetal period, the cecum is similar in appearance to
both small and large intestine with a well-developed epithelial layer forming a lumen. (E) The cecum in the adult mouse is similar in diameter and appearance
to the large intestine.
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arising from the GIT.
The fibroblast growth factors (FGFs) are a family
comprising at least 22 members of signaling molecules
involved in different aspects of organogenesis. FGF10 is
associated with instructive mesenchymal–epithelial inter-
actions, which occur during branching and budding mor-
phogenesis. The expression of Fgf10 in the developing
lung mesenchyme anatomically correlates with eventual
sites of epithelial bud formation (Bellusci et al., 1997).
FGF10 has also been shown to be a potent chemoattrac-
tant for the distal lung epithelium (Park et al., 1998;
Weaver et al., 2000). Mice deficient for Fgf10 exhibit
multiple organ defects including lung, limb, and mamma-
ry gland (De Moerlooze et al. 2000; Mailleux et al.,
2002).
FGFs act through tyrosine kinase transmembrane recep-
tors (McKeehan et al 1998). The FGF receptor (Fgfr) gene
family has genetic linkage to skeletal dysplasias and
autosomal dominant craniosynostosis syndromes (De
Moerlooze and Dickson, 1997). However, the FGF recep-
tor family has not been implicated in gastrointestinal
malformation in humans. In mammals four FGF receptors
have been identified. They are composed of an extracel-lular domain containing two to three immunoglobulin-like
domains, a transmembrane domain, and an intracellular
tyrosine kinase domain. Alternative splicing of the Fgfr2
gene generates two isoforms, termed IIIb and IIIc, which
will differentially bind different FGF ligands. FGFR2IIIb is
found primarily in epithelial cells and is activated by
FGF1, 3, 7, 10, and 22. FGFR2b-IIIc is located primarily
in the mesenchyme and, with the exception of FGF1, is
activated by a different set of ligands (Ornitz and Itoh,
2001).
A null mutation of Fgfr2 results in peri-implantation
lethality at gestational age E4.5–E5.5 (Arman et al.,
1998). A homozygous hypomorphic allele results in death
at around E10.5 with no limb buds and a defective
placenta. (Xu et al., 1998). A Cre-mediated excision was
used to generate mice lacking the Fgfr2 IIIb isoform
(Fgfr2b). These mice retained a normal FGFR2 IIIc
receptor. The Fgfr2b / embryos are viable until birth
at which time they have respiratory failure secondary to
lung agenesis. They also exhibit severe defects in the
development of the limbs, anterior pituitary gland, mam-
mary gland, salivary glands, inner ear, teeth, skin, and
skull (De Moerlooze et al., 2000; Mailleux et al., 2002).
Similar defects were observed in Fgf10 /  embryos,
Fig. 2. The Fgf10–Fgfr2b pathway plays a critical role in the development of the cecum. Whole mount in situ hybridization was performed on embryos at
selective gestational stages. (A) Fgf10 expression was evaluated at E10.5 in the entire gastrointestinal tract (GIT). Fgf10 expression is noted in the most distal
mesenchymal portions of the developing lung (labeled lu), the mesenchyme surrounding the foregut, which will develop into the stomach and pancreas (labeled
st and pa, respectively). In addition, in the second loop of the intestine (the eventual site of cecal development), there is discreet expression of Fgf10 in the
lateral portion of the mesenchymal tissue of the gut tube preceding the formation of the early mesenchymal cecal bud (labeled cecum with arrow). (B) The
expression of Fgf10 remains specific to the cecum compared to the small and large intestine immediately adjacent at E12.5 during the time period when the
cecum is in an elongation phase. (C) A magnified view of the cecum at E12.5 illustrates the expression of Fgf10 within the mesenchymal tissue surrounding the
epithelium. (D) The expression of Spry 2 is noted at E14.5 and shows a modest specificity within the cecal epithelium. (E) At E11.5, Bmp4 is expressed most
intensely at the very apex of the mesenchymal cecal bud. (F) Shh is expressed equally within the epithelial layer of the cecum, small and large intestines at
E13.5. (G) The expression of Fgfr2 is shown within the epithelium of the entire GIT at E 12.5. (H) A high magnification of the cecum at E12.5 illustrates the
expression of Fgfr2 to be localized to the epithelium with no specificity for cecum compared to the surrounding small and large intestine. (I) Wnt2b is also
expressed in the epithelium with no specificity for cecum at E12.5. (J) The expression of Pitx2 is highly specific to the mesenchyme of the cecum at E11.5. (K)
A magnified view of the cecum at 11.5 demonstrates the intensity and specificity of Pitx2 for the tissues of the cecum. (L) The expression of Tbx4 is found
equally within the epithelium of the small intestine, cecum, and large intestine at E 11.5.
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during embryonic development (Ohuchi et al., 2001).
While much is known about the role of Fgf10 and
Fgfr2b in many organs, little is known about their role in
GIT development. The cecum offers an ideal opportunity
to assess the role of these signaling molecules because of
its simple and reproducible developmental morphology as
a single bud arising from the midgut. We report herein the
temporal and spatial expression of key genes controlling
budding morphogenesis including Fgf10, Fgfr2, Spry2,Bmp4, Shh, Pitx2, Tbx4, and Wnt2b using whole mount
in situ hybridization. The morphology of wild type cecum
is compared with Fgf10 / and Fgfr2b / mutant ce-
cum between E12.5 and E14.5. Bromodeoxyuridine
(BrdU) incorporation into DNA was used to evaluate
proliferation in wild type and mutant cecum. In vitro
assays with isolated cecal endoderm in the presence of
FGF7 or FGF10 allowed us to test FGF function in a
chemically defined organ culture system. We provide
evidence that FGF10 is expressed specifically in the
Fig. 3. Cecal development in Fgf10 / and Fgfr2b / mutants. Arrow points to the cecum in all specimens. (A) The wild-type cecum with adjacent small and
large intestine at E12.5 demonstrates a well-developed bud with both epithelial and mesenchymal layers identifiable. (B) At E13.5, the wild-type cecum has
undergone considerable elongation of both epithelial and mesenchymal layers. (C) The progressive elongation of the cecum is evident at E14.5 in the wild type;
note that the epithelium has undergone sufficient development to form a luminal structure. (D) The Fgf10 /  mutant cecum has developed an early
mesenchymal bud considerably smaller than the wild type. The epithelial layer has not invaded this early mesenchymal bud. (E) In contrast to the wild-type
cecum, the Fgf10 / mutant at E13.5 has undergone only minimal elongation. The epithelial layer is still absent from the mesenchymal bud. (F) In contrast to
the luminal cecum of the wild type, the E14.5 Fgf10 / mutant has no epithelial layer. The early mesenchymal bud has failed to continue development and is
only a rudimentary counterpart to the wild type organ. (G, H, I) The Fgfr2b /  mutant is presented at stages E12.5, E13.5, and E14.5, the cecal development is
essentially equivalent to the Fgf10 /  mutant. At E12.5 (H), note the small cecal remnant of epithelial invagination. This remnant is also shown sectioned in
the BrdU assay.
R.C. Burns et al. / Developmental Biology 265 (2004) 61–7464mesenchyme of the cecal bud and functions through
FGFR2b (expressed throughout the cecal epithelium) to
promote increased epithelial proliferation at the apex of
the cecal bud.Materials and methods
Mutant embryos
Fgf10 / and Fgfr2b / were generated as previously
described (De Moerlooze et al., 2000; Sekine et al., 1999)
on the C57Bl/6 background. C57Bl/6 or wild-type (Wt)
littermates were used as controls. Embryos from Wt
(E10.5–E18.5), Fgf10 / (E10.5–E14.5, n = 5 at each
stage), and Fgfr2b / (E10.5–E14.5, n = 5 at each stage)
were evaluated.Biological samples
All embryos to be used for in situ hybridization were
removed from the uteri and fixed in 4% paraformaldehyde
solution in PBS at 4jC. The fixation time was adjusted for
the age of gestation as follows, E10.5 = 1 h, E11.5 = 1.5 h,
E12.5 = 2 h, 13.5 = 3 h, E14.5 = 4 h. The samples were then
washed twice in PBS for 5 min, then stored overnight in
70% ethanol and transferred to 100% ethanol until needed.
Alternatively, the GIT was isolated from the embryos and
placed in PFA before dehydration in 100% ethanol and
photographed. All embryos for BrdU and TUNEL immu-
nohistochemistry were preserved in Metacarn (120 ml
methanol, 60 ml chloroform, 20 ml acetic acid) for time
periods equal to that of the stage matched 4% paraformal-
dehyde samples. They were then stored directly in 100%
ethanol.
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The murine cDNA used as templates for riboprobes was
a 584-bp Fgf10 fragment (described by Bellusci et al.,
1997), a 1.5-kb full-length Bmp4 (Winnier et al., 1995), a
948-bp Spry2 (Mailleux et al., 2001), a 642-bp Shh clone
and a 630-bp Wnt2b clone (provided by J.C. Ipsizua
Belmonte), a 1.3-kb Tbx4 (provided by Papaioannou), and
a 560-bp PCR cloned fragment for Pitx2 (Pitx2 F gcagag-
gactcattcacta; Pitx2 R tataaacgtacggaggagtc). The whole
mount in situ hybridization protocol has been described
(Winnier et al., 1995). To evaluate the expression of the
above genes the GIT was dissected and treated as previously
described at various stages of development ranging from
E10.5 to E14.5. Photomicrographs were then taken of the
desired tissue.
Proliferation analysis
Intraperitoneal injection of 0.2 ml bromodeoxyuridine
(BrdU, Amersham Biosciences UK Limited) was given to
pregnant female mice at stages E11.5–E13.5 (Wt) and
E11.5–E12.5 Fgfr2b /. The mice were sacrificed after
15 min. The cecum was dissected from embryos, pre-
served in metacarn solution, and processed for paraffin
sectioning. Uniform dissection and orientation of the
tissue was preserved for clear identification of structures.
The cecum was oriented away from the label of the
embedding cassette or slide, while the small and large
intestine toward label. The large intestine was always
transected as a long segment while the small intestine
was uniformly short. The embedded specimens were
sectioned at 7 Am. The sections were then treated with
monoclonal anti-bromodeoxyuridine (Clone BU-1) RPN
202 as recommended by the manufacturer (Amersham
Biosciences). FITC-labeled anti-mouse secondary antibod-
ies were used. Vectashield was used as a mounting
medium. The sections were then photographed. The
epithelial cells of the cecum as well as the adjacent
small and large intestine were counted for the number
of total number of cells and BrdU-labeled cells. The
percent of BrdU-labeled cells is reported as the prolifer-
ative index by tissue (small intestine, large intestine, and
cecum).
Further evaluation of the proliferation in the cecum is
shown as the proliferative rate of the epithelial cells at the
apex of the cecum, compared to that of the epithelial cells of
the body of the cecum.
The cells were determined to be from the apex if they
were distal to a perpendicular line drawn at the most distal
portion of the lumen. Cells proximal to this line and distal to
the right angle formed as the cecum branches off from the
small and large intestine were considered to be the body or
sidewall of the cecum.
The apical cells were identified as those cells lying
distal to the most distal extent of the lumen (tip of thececum). All cells distal to this line were considered to be
apex (mean number of apical cells at E11.5 (11.5 F 2.3);
E12.5 (16.4 F 2.7); E13.5 (10.5 F 0.6)). All cells
proximal to this point were considered to be part of the
body of the cecum (mean number of body cells at E11.5
(12.3 F 0.6); E12.5 (22.9 F 3.2); E13.5 (41.0 F 3.4)).
Please see Fig. 5C. The total number of cells was counted
and compared to the number of BrdU-labeled cells in the
same area of interest or to adjacent areas. The rate of
proliferation was determined by dividing the BrdU-labeled
cells by the total number of cells within respective regional
anatomic locations. The proliferative rate within the cecum
was then examined in the epithelium at the apex of the
cecum, as compared to the epithelium of the body of the
cecum.
The proliferative rate was also examined in the
Fgfr2b / mutant cecum. Stages E11.5 and E12.5 were
chosen as this is the time point at which the mutant cecum
begins to show a phenotypic deviation from normal
development. The mutant cecum only has a diminutive
bud of epithelium at the site of early mesenchymal cecal
bud formation. This will be described in detail below. As
there are no cecum-specific cell markers, we relied upon
uniform embedding and sectioning as described earlier for
anatomic identification of structures. In the mutant, the
body of the cecum fails to develop; therefore, the cells in
the region of the small cecal bud were classified as apical
and were the only cells counted. The proliferation rate was
calculated.
Proliferation assays were also carried out with the cecal
epithelium grown in vitro in Matrigel with FGF7 and
FGF10 (see in vitro assay) after incubation of the explants
with BrdU (Stock BrdU solution (Amersham Bioscience)
diluted 1:1000 with PBS) for the last 6 h of the 48-h culture
period.
Cell death analysis
Pregnant Wt, Fgf10 /, and Fgfr2b / female mice
between E11.5 and E18.5 were sacrificed. The cecum
was dissected from embryos, preserved in metacarn
solution, and oriented on slides as previously described.
Lung and cecum explants from the in vitro assays were
also fixed in metacarn and processed for paraffin section.
The cecum and explants were then imbedded in paraffin
wax and 7-Am sections were prepared. The ‘‘In Situ Cell
Death Detection Kit, Fluorescein’’ kit for detection and
quantification of apoptosis at single cell level, based on
labeling of DNA strand breaks (TUNEL technology),
from Roche Applied Science was used per standard
instructions.
Smooth muscle actin expression
Pregnant Wt, Fgf10 /, and Fgfr2b / female mice
between E11.5 and E18.5 were sacrificed. The cecum was
Fig. 4. Gene expression in the mutant and SMA expression. In situ hybridization (A–D) and immunofluorescence analysis of smooth muscle actin (E–H) were
performed on Fgf10 / and Fgfr2b /  ceca. Similar data were obtained for Fgf10 / and Fgfr2b / ceca. (A) Shh is present within the epithelial layer of
E12.5 Fgfr2b /  cecum, with equal expression in small intestine, cecum, and large intestine. The cecum is shown with a white arrow. Note the absence of an
epithelial layer within the cecal remnant. (B) Identical expression is seen with Tbx4 in E11.5 Fgf10 / cecum. (C and D) Pitx2 and Bmp4 are still expressed in
the mesenchyme of the E11.5 Fgfr2b /  cecum. (E) The expression of SMA in the Wt cecum is first detected at E13.5. Note that the expression in the cecum
(white arrow) lags behind that of the large intestine. (F) The differentiation of SMA proceeds from proximal to distal from the mesenteric side of the bowel wall
to the anti-mesenteric side. Note that at E14.5, the Wt cecum (white arrow) has increased in size and the differentiation of SMA has progressed. (G) The
Fgfr2b /  mutant demonstrates the differentiation of the SMAwithin the small and large intestine to be equivalent to the Wt. The mesenchymal cecal remnant
does not differentiate into SMA. (H) A similar observation is made at E18.5.
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oriented on slides as previously described. Slides were then
treated with SigmaR ‘‘Monoclonal anti a-smooth muscle
actin, clone 1A4, Cy3 conjugate’’ via standard protocol. All
samples were mounted with Dapi-labeled VectashieldR and
photomicrographs were taken.
In vitro assay of isolated embryonic cecal epithelium
E13.5 mouse cecum and lungs (used as control) were
isolated and treated with collagenase A (0.5 mg/ml in
PBS for 30 min at 37jC). The cecal epithelium was
separated from the mesenchyme using fine tungsten
needles and transferred into Matrigelk, diluted 1:1 with
culture medium (5% FCS (DMEM: F12) penicillin/strep-
tomycin + glutamine) in a four well Nunc. Polymerization
of the Matrigelk was triggered by transferring the
Matrigelk at 37jC for 30 min. After polymerization,
500 Al of culture medium containing the growth factor
FGF10 (500 ng/ml) or FGF7 (250 ng/ml) was gently
added to the Matrigelk layer. The explants were grown
for 48 h at 37jC in a 6% CO2 incubator. Six hours
before fixation, BrdU (diluted 1/1000) was added for
labeling the proliferating cells. The samples were then
fixed in metacarn and processed for proliferation–apopto-
sis analysis.Results
Normal development of the cecum
The entire gastrointestinal tract at E12.5 is shown in Fig.
1A to demonstrate the relative position of the cecum
compared to proximal and distal structures (i.e., lungs,
stomach, small and large intestine). The panels labeled Figs.
1B–E demonstrate the progressive development of the
cecum. E11.5 (Fig. 1B) is the first stage at which there is
clear anatomic evidence of an early mesenchymal cecal bud
arising at the junction of the future small and large intestine.
This early mesenchymal bud demarcates the site of the
cecum. At E13.5 (Fig. 1C), there is a clearly identifiable
epithelial layer that invades the mesenchymal bud as the
structure progressively elongates. The epithelial and mes-
enchymal layers develop in a stereotypic and uniformly
synchronous fashion. Note that the diameter of the cecal
cylinder is roughly equal to that of the neighboring small
and large intestine. From E13.5 to E18.5, the cecum under-
goes elongation to yield a luminal structure with well-
developed mesenchymal and epithelial components. Note
that at E18.5, Fig. 1D, the cecum has sufficient length to
fold back onto itself. Fig. 1E demonstrates the cecum of an
adult mouse. The organ is well developed and similar in
caliber and gross appearance to its adjacent large intestine.
Fig. 5. Proliferative index as measured by BrdU assay. Table A presents the mean epithelial proliferative index of the cecum, small and large intestine at E11.5,
E12.5, and E13.5. The mean proliferative index, standard deviation, and sample size are presented. There was no statistically significant difference in the
proliferative rates of these tissues. Table B presents the regional epithelial proliferative index within the cecum when the apical cap of the cecum was compared
to the body. The mean proliferative index, standard deviation, and sample size are presented. The apical epithelial cells demonstrate a significantly higher rate
of proliferation compared to the body at all stages studied (E11.5 P < 0.001, E12.5 P < 0.001, E13.5 P < 0.001). This information suggests that cecal elongation
is at least in part a result of an increased rate of proliferation within the cells at the apex of the cecum. (C) Wild-type BrdU-labeled section at E12.5
demonstrates the location of apical epithelial cells (yellow) compared to epithelial cells of the cecal body (red) as described in the Materials and methods. Note
the concentration of BrdU-labeled cells at the apex of the cecum. (D) A BrdU-labeled Fgfr2b/ mutant demonstrates the small remnant of cecal epithelium
(aqua). Note the difference in BrdU staining in the apex of the wild type (yellow) compared to the Fgfr2b/ mutant (aqua). (E) The proliferation rates of the
wild-type apex and body as well as the Fgfr2b / apex are presented graphically to highlight the proliferation rates. The cells in the apex of the mutant are
proliferating at a rate essentially equal to that of the body of the wild type and significantly slower than wild-type apical epithelial cells.
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The Fgf10–Fgfr2b pathway has been shown to play a
critical role in orchestrating the branching process in the
lung and other ramified structures. Using whole mount in
situ hybridization, the expression of Fgf10 and Fgfr2b was
investigated between E10.5 (a stage where there is no
distinct epithelial or mesenchymal bud detectable) and
E12.5. Several relevant upstream and downstream regula-
tors of this pathway were also examined. As previously
reported, the expression of Fgf10 at E10.5 (Fig. 2A) within
the foregut is shown to be specific to the mesenchyme of the
lung, stomach, and pancreas (Bellusci et al., 1997b;
Bhushan et al., 2001). We show for the first time thatFgf10 is also specifically expressed in the lateral mesen-
chyme of the second loop of the intestine, which is the
anatomic location of the cecum. The expression of Fgf10
therefore precedes mesenchymal cecal bud formation. At
E11.5, Fgf10 is specifically expressed in the mesenchymal
tissue of the early cecal bud (data not shown). By E12.5
(Fig. 2B), the GIT has undergone considerable develop-
ment. The small intestine has elongated. The lung is now
well ramified and the fundus of the stomach is easily
identified. The expression of Fgf10 is evident in the distal
lung, the fundus of the stomach, and the cecum. The cecum
shown in a magnified view (Fig. 2C) demonstrates the
highly specific expression of Fgf10 in the mesenchyme
surrounding the early cecal bud. In situ hybridization on
Fig. 6. The effects of FGF7 and FGF10 on tissue culture. The tissue in the upper right hand corner of all boxes represents the cecum or lung epithelium at E13.5
(t = 0 h). The tissue centered in each panel is the same sample after 48 h of tissue culture in labeled media. (A) Cecal epithelium after 48 h of tissue culture as
described. Note that the tissue has decreased in size and is now considerably smaller than the samples in B and C. This is in contrast to control lung epithelium
(D), which did not decrease in size. (B) Cecal epithelium grown in tissue culture media supplemented with FGF7 has increased in both length and diameter
compared to control (A). (C) Cecal epithelium grown with FGF10 supplementation also shows an increase in size and diameter compared to wild type. Note
that although there is an increase in size in both B and C, there is no significant difference in morphology as seen in the lung epithelium treated with FGF7 and
FGF10. (D) Lung epithelium grown in tissue culture shows a modest increase in size without significant change in morphology. (E) Lung tissue with
supplementation of FGF7 shows a dramatic increase in size. Specifically, existing lung ramifications have increased in diameter. (F) The lung epithelium
supplemented with FGF10 also shows an increase in size. This increase in size is a result of an increased number of ramifications as opposed to an increase in
their size.
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found in the mesenchyme located adjacent to the epithelium
but rather in the peripheral mesenchyme (data not shown).
The expression of Fgf10 is highly specific for the mesen-
chyme of the cecum at time points when this structure is in
its early phases of elongation.
FGF10 interacts through at least two receptors (FGFR1-
IIIb and FGFR2-IIIb). Figs. 2G and H show the expression
of Fgfr2 (a probe that recognizes both Fgfr2b and Fgfr2c)
mostly in the epithelium. Fgfr1b was also detected in the
cecum as well as adjacent small and large intestine by RT-
PCR (data not shown). Other potential activators of FGFR2-
IIIb, namely FGF 1, 3 and 7, were also evaluated for
expression. None were expressed in the cecum by whole
mount in situ hybridization, therefore suggesting a unique
relationship between FGF10 and FGFR2b with limited
redundancy at the level of the ligand.
Several genes, which are involved in controlling the
activity of FGF10, were investigated for differential expres-
sion in the cecum from E11.5 to E14.5. The expression of
Bmp4 is shown in Fig. 2E. Note the specific expression of
Bmp4 in the mesenchyme of the cecum. Bmp4 expression is
most intense at the apex of the developing cecum at E11.5.
The expression of Bmp4 in the mesenchyme has been
confirmed on sections (data not shown). Shh, whose gene
product is known to be involved in the negative regulation
of Fgf10 expression, is shown at E13.5 (Fig. 2F). Shh is
expressed in the epithelium equally in the small intestine,
large intestine, and cecum. The expression of Sprouty2 was
only detected from E14.5 and demonstrates a modestlyincreased expression in the epithelium of the cecum (Fig.
2D). No expression of Spry2 was detected at stages E11.5
and E13.5 (data not shown). Wnt2b is expressed in the
epithelium of the developing cecum at an intensity equal to
that of the adjacent structures at stage E12.5 (Fig. 2I).
The expression of Pitx2, thought to be part of a regula-
tory loop controlling Fgf10 expression, was found to be
intense and specific for the mesenchyme of the cecum at
E11.5 as shown in comparison to the whole gut (Fig. 2J) and
in a highlighted view of the cecum (Fig. 2K). Tbx4, a known
upstream regulator of Fgf10, was expressed in the epitheli-
um of the entire gastrointestinal tract, including the cecum
(Fig. 2L) in a manner similar to Shh.
Cecal development in Fgf10/ and Fgfr2b/ mutants
The GIT was dissected from wild-type and mutant
embryos at E12.5 through E14.5. A normal cecum at
E12.5 is shown in Fig. 3A, the cecum is indicated in all
photos with an arrow. The cecum is shown attached to a
portion of the small and large intestine. At this relatively
early stage of intestinal development, the mesenchymal
tissue is well differentiated from the epithelial tissue. Two
distinct layers of tissue are therefore present in the cecal
bud. At E13.5 (Fig. 3B), the cecum has undergone progres-
sive elongation at the junction of the large and small
intestine. The epithelial layer can be distinguished visually
from the mesenchymal tissue. By E14.5 (Fig. 3C), the
normal cecum is a well-developed tube with easily distin-
guishable epithelial and mesenchymal layers.
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are shown in Figs. 3D–I. Similar phenotypes are observed
and we will therefore describe them together. In the absence
of Fgf10 or Fgfr2b, normal development of the cecum is
greatly altered. At E12.5 (Figs. 3D and G), a small conden-
sation of mesenchymal tissue is noted. This early cecal bud
is much smaller than the wild-type cecum in Fig. 3A. The
epithelial layer does not invade the mesenchymal tissue. At
E13.5, the Fgf10 / and Fgfr2b / mutant ceca display
mesenchymal buds that have failed to continue development
(Figs. 3E and H). There is no progressive elongation of the
structure. The ingrowth of epithelial tissue into the early
cecal bud has failed to occur and only a rudimentary
epithelial structure remains underneath the mesenchymal
bud. By contrast, the wild-type cecum has begun the process
of progressive elongation with a distinct layer of epithelium
present. Similar observations are made at E14.5 for both
mutants.
Analysis of the mutant cecum
The expression of selected genes was evaluated in the
Fgfr2b / mutant at E11.5 and E12.5. Similar results were
obtained in Fgf10 / mutants. Epithelial expression of Shh
(at E12.5) and Tbx4 (at E11.5) is present throughout the gut
including the cecal rudiment (Figs. 4A and B). We have also
investigated the expression of genes expressed specifically
in the mesenchyme. At E11.5, Bmp4 and Pitx2 are strongly
expressed in the mesenchymal bud rudiment. As a marker of
mesenchymal differentiation, we analyzed the expression of
smooth muscle actin in the wild-type and mutant ceca at
different stages. SMA expression in the cecum is first noted
at E13.5. The expression of SMA appears to proceed in a
proximal to distal fashion, with the side of the bowel wall
closest to the mesentery developing before the anti-mesen-
teric side. Large intestinal SMA expression is noted to be
more intense and organized at this stage (Fig. 4E). By
E14.5, the expression pattern of SMA has intensified (Fig.
4F) and remains oriented toward the mesenteric side of the
bowel compared to the anti-mesenteric side. The expression
in the most distal, apex of the cecum, lags behind that of the
proximal cecum. By E18.5, Wt SMA expression in the
cecum is equal to that of the small and large intestine with
two thin distinct layers on the outermost portion of the
bowel wall (data not shown).
The expression of SMA in the cecal remnant of both
Fgf10/ and Fgfr2b/ mutants is absent. At E14.5, the
expression of SMA in the small and large intestine is
organized and proceeding at a rate equivalent to Wt. The
cecal remnant however continues to lack expression (Fig.
4G). The absence of SMA expression in the cecal remnant
continues throughout embryogenesis. At E18.5, the cecal
remnant has no expression of SMA as shown in Fig. 4H.
SMA expression pattern was equal in both Fgf10/ and
Fgfr2b/ mutants (data not shown). We also investigated
the extent of vascular development in the wild-type andmutant ceca using intracardiac India ink injection in E11.5
embryos. There was no significant change in the arterial
vascular cascade providing blood flow to the cecum in the
Fgfr2b / mutant compared to Wt. Both specimens dis-
played intact mesenteric arterial cascades which stained with
India ink up to and including the bowel wall (data not
shown).
FGF10 has been shown to act on the epithelium to trigger
proliferation (Bellusci et al., 1997). We have therefore
carried out the analysis of proliferation during development
of wild-type and mutant ceca.
Cecal elongation is a result of a regional increase of
epithelial cell proliferation at the apex of the cecum
The rate of proliferation of epithelial cells was analyzed
using BrdU incorporation (see Materials and methods).
First, the proliferative rate within the epithelium of the
cecum was compared to the proliferative rate within the
epithelium of the small and large intestine at E11.5, E12.5,
and E13.5. The table in Fig. 5A summarizes the results in
wild type embryos and shows that at all stages considered,
the proliferation rate of the epithelial cells were not signif-
icantly different between the cecum, and small and large
intestine. For example, at E11.5, the average proliferation
rate for the cecum, small and large intestine is 53.4 F
15.5%, 47.2 F 9.6%, and 50.3 F 11.7%, respectively. The
difference among the tissues was not statistically significant
(P = 0.57).
The wild-type cecal epithelium was further evaluated for
regional proliferation (Fig. 5B). The epithelial cells were
divided by regional anatomical location, apex vs. body as
described earlier in Materials and methods. Fig. 5C shows a
magnified view of the wild-type cecal bud. The yellow box
differentiates the cecal apex from the cecal body. The red
box differentiates the cecal body from the small and large
intestine. Fig. 5B shows that the mean proliferative index of
the apex at stage E11.5 is 69.4 F 5.3% compared to 47 F
7.9% for the body of the cecum. This difference is statis-
tically significant (P < 0.001). Similar results are obtained
at E12.5 (P < 0.0001) and E13.5 (P < 0.0001).
The proliferative rate within the Fgfr2b /  mutant
epithelium was then compared to the wild type. Fig. 5D
shows that the mutant cecum has only an epithelial rudiment
at the site of formation of the early mesenchymal bud. This
structure is identified by localization of the mesenchymal
bud and uniform embedding and sectioning as described
earlier. The Fgfr2b / mutant cecum does not elongate to
form a tubular structure like the wild-type cecum prohibiting
attempts to count cells in the body of the cecum. The mutant
specimens were treated in a manner identical to wild-type
tissues. We found that the number of cells proliferating in
the epithelial rudiment (44 F 6% at E11.5 and 48.5 F 6.7%
at E12.5) was similar to the proliferation observed in the
body of the wild-type cecum. This difference is not statis-
tically significant.
Fig. 7. Effect of FGF7 and FGF10 on epithelial cell proliferation and apoptosis. Tissues shown in Fig. 6 were prepared and sectioned as described in Materials
and methods (number of BrdU or TUNEL-stained epithelial cells divided by the total number of epithelial cells will be listed). (A) Control cecal epithelium
treated with BrdU shows almost no proliferation. (B) Cecal epithelium supplemented with FGF7 shows abundant BrdU labeling indicating active proliferation
under the influence of FGF7. (C) Cecal epithelium supplemented with FGF10 also shows abundant proliferation. (D) Control cecal epithelium treated with
TUNEL demonstrates modest staining of the epithelial layer (e). The small rim of mesenchymal cells (m) not completely removed before tissue culture was
noted to have intense staining with TUNEL indicating active apoptosis. (E) Cecal epithelium (e) supplemented with FGF10 showed no staining with TUNEL
indicating FGF10 is sufficient to prevent epithelial apoptosis. Note that there is a modest level of mesenchymal (m) apoptosis, but less intense than in control
mesenchyme. (F) The effect of FGF10 on cecum was confirmed in lung tissue used as control where results were similar to cecum (E).
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development of wild-type and mutant ceca. TUNEL staining
of cecal sections between E11.5 and E18.5 in wild-type
Fgf10 / and Fgfr2b / mutants demonstrated only a rare
and unorganized staining for TUNEL (data not shown). The
presence and location of TUNEL-stained cells were not
selective for anatomic location and tissue type (epithelium
vs. mesenchyme or mutant vs. wild type).
FGF10 has been described as triggering a proliferative as
well as a chemotactic response on isolated lung epithelium
(Park et al, 1998; Weaver et al., 2000). We have therefore
carried out a biological assay to distinguish between these
two activities.
Effects of FGF10 and FGF7 on isolated cecal epithelium in
Matrigelk
The direct effect of FGF10 and FGF7 on cecal epithelium
was investigated by growing E13.5 isolated cecal epithelium
in Matrigelk in the absence or presence of recombinant
FGF10 or FGF7 proteins (Figs. 6A–C) for 48 h. Isolated
lung endoderm was also used as a control for the differential
activity of FGF10 and FGF7 (Bellusci et al., 1997, Figs.
6D–E). In spite of good dissecting techniques, we failed tocompletely remove the mesenchyme from the cecal epithe-
lium. This limitation is due to the nature of the mesen-
chyme, the size of the cecum, and its particular shape that
rendered difficult the separation of the mesenchyme from
the epithelium without damaging the epithelium. To con-
sider the importance of this limitation, we also used rat ceca
at E14 which because of their larger sized allowed a much
better separation of the epithelium and mesenchyme. No
differences were observed between rat and mouse isolated
cecal endoderm in presence of FGFs (data not shown).
In the absence of exogenous FGF, the epithelium failed
to proliferate and died (Fig. 6A). With 250 ng/ml of FGF7,
the survival of the epithelium was greatly enhanced and an
increase in length and diameter was observed (Fig. 6B).
Similar results were obtained with 500 ng/ml of FGF10
(Fig. 6C). However, no change in the overall shape of the
cecal bud epithelium was seen in the presence of FGF10,
further supporting the conclusion that the primary function
of FGF10 on the cecal epithelium is to promote prolifera-
tion. A considerable difference was observed with isolated
lung epithelium, which has been shown to respond to FGF7
by proliferating and to FGF10 by undergoing morphogen-
esis (Bellusci et al., 1997 and Figs. 6D–F). The control lung
epithelium shown in Fig. 6D shows no significant increase
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decrease in size as the control cecum did. Endogenous
production of FGF1 by the lung epithelium at that stage
may explain this observation (Bellusci et al., 1997). The
lung epithelium grown in the presence of FGF7 (250 ng/ml)
is shown in Fig. 6E. There is an increase in the diameter of
the epithelium at points where ramification has already
occurred. The points of ramifications have increased in size
and there are no new ramifications present. Lung epithelium
grown in tissue culture supplemented with FGF10 (500 ng/
ml) displays a distinct morphology (Fig. 6F). The lung
epithelium at points of ramification has elongated. The
tissues have increased in size along a longitudinal axis to
form multiple cylinders. There are new buds present after 48
h of tissue culture.
Effects of FGF7 and FGF10 on cecal epithelial cell
proliferation and apoptosis
The effect of FGF7 and FGF10 on cecal epithelial cell
proliferation and apoptosis was analyzed by BrdU incorpo-
ration (Figs. 7A–C) and TUNEL (Figs. 7D–F) assays.
Fig. 7A shows very limited proliferation of the control
cecal epithelium grown in tissue culture without the sup-
plementation of FGF7 or FGF10 with only 0.5% of epithe-
lial cells stained for BrdU. Figs. 7B and C demonstrate that
there is a large increase in BrdU positive epithelial cells
(35% and 31%, respectively) in presence of these growth
factors. These results therefore indicate that FGF7 and
FGF10 are able to trigger proliferation of cecal bud epithe-
lium in vitro.
The endoderm explants were also analyzed for apoptosis
by staining with TUNEL. Fig. 7D demonstrates that in
absence of FGF10, an isolated cecum explant has significant
TUNEL staining (7% of labeled cells) and is therefore
undergoing apoptosis. There is also an intense staining
within the contaminating mesenchymal cells surrounding
the epithelium. In contrast, FGF10 completely prevents
apoptosis in the cecal epithelium while positive staining is
clearly shown in the surrounding mesenchyme (Fig. 7E).
Similar results are observed with isolated lung epithelial
explants grown in presence of FGF10 (Fig. 7F).Discussion
The development of a normal cecum can be subdivided
into three basic steps including bud induction, bud elonga-
tion, and bud arrest. We show that Fgf10 is specifically
expressed in the mesenchyme above the future cecal epi-
thelial bud, whereas Fgfr2b is found throughout the gut
epithelium. Abrogation of Fgf10 or Fgfr2b leads to a similar
phenotype characterized by an arrest of epithelial invasion
into the cecal mesenchymal tissue. However, a bud of
undifferentiated cecal mesenchymal tissue is clearly present
and maintained throughout development. Our results indi-cate that during cecum development, mesenchymal FGF10
acts chiefly through the epithelial FGFR2b receptor to
trigger the invasion of epithelial tissue via an increased rate
of epithelial proliferation at the tip of the cecum. The
specific role of FGF10 and FGFR2b during early cecum
development appears therefore to be most critical in the
elongation phase.
Fgf10–Fgfr2b pathway is not essential for the induction of
the cecal bud
Fgf10 is discretely expressed in the mesenchyme of the
herniated GIT at the location of the future cecum (Figs. 1
and 2). This expression is present before the bud begins to
form, seemingly indicating a very early role for Fgf10 in the
induction of the bud. However, despite this early expression,
the bud induction does indeed occur in null mutant embryos
(Fgf10 / and Fgfr2b /, as seen in Fig. 3), although this
bud then fails to develop into a luminal structure. This
suggests that cecal bud induction does not require the
function of the Fgf10–Fgfr2b signaling pathway. This
hypothesis has been supported in other organ systems
including pancreas (Bhushan et al., 2001) and lung (Bel-
lusci, data not shown), where rudimentary bud induction
also occurs despite inactivation of either Fgf10 or Fgfr2b.
Fgf10 and Fgfr2b are critical for the elongation phase of
cecal bud development
Fgf10 and Fgfr2b are expressed very early (E10.5),
before bud induction occurs and this expression is main-
tained during bud elongation (until at least E14.5), indicat-
ing a likely role in supporting the elongation phase of cecal
development. Restricted mesenchymal Fgf10 expression at
the apex of the lung epithelial bud during the early pseu-
doglandular phase has been associated with directional
growth of the lung bud epithelium (Bellusci et al., 1997b).
However, in the cecum, Fgf10 expression is not maintained
at the apex of the cecal bud but found throughout the cecal
mesenchyme from E12.5 onwards, suggesting that FGF10
may act as a general proliferative factor for the cecal
epithelium. Interestingly, our current data demonstrate a
significant increase in cell proliferation at the apex of the
cecal bud between E11.5 and E13.5. We propose that this
increased differential proliferation is important for cecal
epithelial bud outgrowth from the primitive intestinal tube.
The homogenous expression of Fgf10 in the cecal mesen-
chyme suggests that FGF10 activity may be inhibited in the
proximal cecal epithelium and only active in the distal
epithelium. This inhibition could be achieved by the ex-
pression of tyrosine kinase receptor inhibitors in the epithe-
lium. However, epithelial Sprouty2 expression is not found
before E14.5 (Fig. 2 and data not shown). We cannot
exclude that other inhibitors such as the Spreds (Wakioka
et al., 2001) could be involved early on to restrict FGF10
activity at the apex. Alternatively, FGF10 may also control
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growth factors at the apex of the bud at early stages of
cecal development. In both scenarios, abrogation of Fgf10
expression will lead to cecum agenesis.
One could theorize that the failure of cecal elongation
was a result of some defect of arterial vascular development
in which the tissues of the cecum did not receive the
requisite nutritional factors required for normal develop-
ment. India ink injection clearly demonstrated that the
failure of cecal elongation is not mitigated by failure of
the vascular development. The arterial vasculature of both
the Wt and Fgfr2b / mutant was equivalent, suggesting
that vasculogenesis can occur independently from epithelial
morphogenesis and may drive this late aspect during cecal
development (Lammert et al., 2001; Matsumoto et al.,
2001).
The similarity of cecal phenotype in both Fgf10 and
Fgfr2b mutants also suggested a unique relationship be-
tween FGF10 and FGFR2b with no redundancy at the level
of the receptor or ligand. This result is further supported as
no other FGFR2b ligand is expressed significantly in the
early developing cecum. Our results therefore implicate an
essential role of this one receptor, one ligand model in early
cecal development.
Mesenchymal FGF10 acts primarily through FGFR2b to
induce cecal epithelial proliferation
FGF10 expression and function has been described in the
developing lung (Bellusci et al., 1997; Min et al., 1998,
Sekine et al., 1999). In this well-defined model of branching
morphogenesis, FGF10 has been suspected to act through at
least two epithelial receptors, namely FGFR1b and FGFR2b
(Ornitz and Itoh, 2001). This hypothesis is supported by the
fact that FGF7 (acting mostly through FGFR2b) and FGF10
display distinct biological responses on isolated lung endo-
derm grown in Matrigelk. While FGF7 induces the ho-
mogenous growth of the epithelium through increased
proliferation, FGF10 induces branch formation through a
process involving increased proliferation and chemotaxis.
We propose that the proliferation response is primarily
triggered by FGF10 action through FGFR2b, while chemo-
taxis involves the activation of a distinct receptor, possibly
FGFR1b. This hypothesis is currently being tested through
the analysis of Fgfr1b / lungs.
In the cecum, Fgf10 / and Fgfr2b / mutant embryos
display almost indistinguishable cecum phenotypes, sug-
gesting that FGF10 acts primarily through FGFR2b. In
addition, our data support a role for FGF10 in controlling
epithelial proliferation. Proliferation analysis in Fgfr2b /
(Fig. 5) and Fgf10 / (data not shown) mutant embryos
demonstrates that the proliferation at the putative apex of the
cecal epithelium rudiment is similar to the one observed in
the body of the wild-type cecal epithelium. The absence of
increased proliferation at the apex of the cecal epithelial bud
in the mutants correlates with the in vitro data demonstratingthat FGF7 and FGF10 exhibit similar activities on isolated
cecum endoderm grown in Matrigelk (Fig. 6). Analysis of
proliferation shows that both FGF7 and FGF10 trigger
increased proliferation of the cecal epithelium in vitro
(Fig. 7).
Growth arrest phase of the cecal bud
A tight control of proliferation is required to reach the
appropriate and reproducible length of the cecum bud. Our
data demonstrate that several key genes encoding positive or
negative regulators of FGF10 activity are expressed in the
developing cecum. For example, Shh, a known negative
regulator of Fgf10 expression at the transcriptional level, is
expressed in the cecal epithelium. It has been shown
recently that Hedgehog Interacting Protein (HIP) can control
the activity of SHH. HIP is a soluble protein produced by
the mesenchyme and able to sequester SHH, thereby abol-
ishing its activity (Chuang and McMahon, 1999). Abroga-
tion of Hip in the embryo leads to lung hypoplasia resulting
from an up-regulation of the SHH pathway associated with a
corresponding decrease in Fgf10 expression (Chuang et al.,
2003). However, the expression and role of HIP has not
been reported in the gut, and a decrease in Hip expression
could take place during the growth arrest phase. In addition,
we show that Sprouty2, a known downstream inducible
negative regulator of the FGF10 pathway (Tefft et al., 1999),
is expressed in the cecal epithelium from E13.5 onwards.
We and others have previously shown that FGF10 induces
the expression of Sprouty2 at the transcriptional level
(Mailleux et al., 2001; Minowada et al., 1999). The absence
of Sprouty2 expression in the epithelium in spite of the
presence of FGF10 before E13.5 suggests the existence of
negative regulators of Sprouty2 expression. Similar obser-
vations have been made during wound healing studies in
adult mouse skin. Expression of Sprouty genes (Sprouty1, 2,
and 4) decreases from a basal level during the first 24–48
h following excisional wounding while FGF7 expression is
clearly increased (Bellusci, unpublished results). This result
supports the existence of negative regulators of Sprouty
expression at the transcriptional level. We also report the
expression of Bmp4 in the cecal mesenchyme at E11.5. This
expression pattern is different from the lung, where Bmp4 is
mostly found in the distal lung epithelium (Bellusci et al.,
1996; Weaver et al., 1999). In addition, Bmp4 expression in
the lung epithelium is partially controlled by FGF10 in the
mesenchyme (Lebeche et al., 1999; Mailleux et al., 2001).
In the cecum, Bmp4 expression in the mesenchyme there-
fore appears to be independent of FGF10. This was con-
firmed by the maintenance of Bmp4 expression in the
Fgf10 / mutant cecal mesenchyme (Fig. 4). The exact
role of Bmp4 during gut development remains to be eluci-
dated. TBX4 is upstream of Fgf10 during lung development
(Sakiyama et al., 2003). Interestingly, Tbx4 expression in
the cecal epithelium suggests that this transcription factor is
not upstream of Fgf10 expressed in the mesenchyme. This
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expression in the mutant cecum (Fig. 4). Wnt2b expression
was detected in the cecal epithelium. WNT2b has been
recently reported to induce Fgf10 expression during limb
development in chick (Kawakami et al., 2001). Fgf10
expression could therefore also be controlled by WNT
signaling. The Pitx2 gene is a member of the bicoid-
homeodomain class of transcription factors that has been
implicated in the control of left–right asymmetry during
organogenesis. It has been proposed that Pitx2 could control
Fgf10 expression during lung development (Marcil et al.,
2003). The interaction among all these potential Fgf10-
upstream regulators is not known so far. Interestingly, Pitx2
expression is still present in the mesenchyme of the
Fgf10 / cecum, suggesting that FGF10 is not required
for the maintenance of Pitx2 expression.
FGF10–FGFR2b pathway may play additional roles
during cecum development
The current paradigm proposes that FGF10 expressed by
the mesenchyme acts on the epithelium (which generally
expresses FGFR1b and 2b). However, a recent report by
Sakaue et al. (2002) suggests that FGF10 expressed in the
fat pad precursor of the developing mammary gland from
E15.5 onwards (Mailleux et al., 2002) could act in an
autocrine fashion to induce differentiation of adipocytes
from the mammary fat pad precursor. The receptors in-
volved in this process are unknown. Branchless, the Dro-
sophila counterpart of FGF10, has been implicated in the
directional growth of ectoderm-derived cells from the tra-
cheal placode (Sutherland et al., 1996). Branchless,
expressed by cells surrounding the placode, acts on the
ectoderm expressing the Fgfr2b ortholog, breathless. An
additional unsuspected function of Branchless in the devel-
opment of the male genital imaginal disc has been recently
reported (Ahmad and Baker, 2002). Here, FGF signal
expressed by ectoderm-derived cells of the male genital
disc induces the FGFR-expressing mesodermal cells to
migrate into the male disc. These mesodermal cells also
undergo a mesenchymal to epithelial transition. Branchless
is also likely to be involved in this process. Recent results
have shown that FGF10 also plays a role in incisor tooth
development in mouse. The mouse incisors are regenerative
tissues that grow continuously throughout life. The renewal
of dental epithelium-producing enamel matrix and the
induction of dentin formation by mesenchymal cells are
performed by stem cells that reside in the cervical loop of
the incisor apex. It has been reported that FGF10 regulates
mitogenesis and fate decision of adult stem cells during the
development of incisors in mouse (Harada et al., 2002).
It is therefore likely that in addition to its early role in
controlling proliferation of the cecal epithelium, the
FGF10–FGFR2b pathway could also control differentia-
tion. The availability of Fgfr2b conditional knock out mice
(De Moerlooze et al., 2000) and the appropriate driver linesto express inducible expression of the Cre recombinase in
the gut epithelium (Saam and Gordon, 1999) should facil-
itate the unraveling of these new functions.Acknowledgments
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